Herpes Zoster Subunit (HZ/su) Vaccine ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
49全身性エリテマトーデス1

49. 全身性エリテマトーデス


臨床試験数 : 993 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05559671
(ClinicalTrials.gov)
February 7, 202326/9/2022Safety of the Herpes Zoster Subunit Vaccine in LupusA Multicenter, Randomized, Double-Blind, Placebo-Controlled, Non-inferiority Crossover Study Evaluating the Safety and Immunogenicity of the Herpes Zoster Subunit Vaccine in Patients With Systemic Lupus ErythematosusSystemic Lupus ErythematosusBiological: Herpes Zoster Subunit (HZ/su) Vaccine;Biological: PlaceboNYU Langone HealthNULLNot yet recruiting18 Years90 YearsAll224Phase 4United States